The thymus in adults infected with the HIV-1 is generally thought to be inactive, both because of age-related involution and viral destruction. We have revisited the question of thymic function in adults, using chest-computed tomography (CT) to measure thymic tissue in HIV-1-seropositive ( n ϭ 99) or HIV-1-seronegative ( n ϭ 32) subjects, and correlating these results with the level of circulating CD4 ϩ and CD8 ϩ T cells that are phenotypically described as naive thymic emigrants. Abundant thymic tissue was detectable in many (47/99) HIV-1-seropositive adults, aged 20-59. Independent of age, radiographic demonstration of thymic tissue was significantly associated with both a higher CD4 ϩ T cell count ( P ϭ 0.02) and a higher percentage and absolute number of circulating naive (CD45RA ϩ CD62L ϩ ) CD4 ϩ T cells ( P Ͻ 0.04). The prevalence of an abundant thymus was especially high in younger HIV-1-seropositive adults ( Յ 39 yr) with CD4 counts in the range 300-500 cells/ l and in older subjects ( Ͼ 40 yr) regardless of CD4 count ( P ϭ 0.03). These studies suggest that the thymus is functional in some but not all adults with HIV-1 disease. ( J. Clin. Invest. 1998.
Introduction
The thymus is important for the generation of naive CD4 ϩ and CD8 ϩ T cells with a diverse T cell receptor repertoire. Although it is active in utero and in early life, intrathymic T cell production diminishes progressively with age. Numerous studies by autopsy (1) (2) (3) (4) (5) (6) (7) (8) , biopsy (9) , and computed tomography (CT) 1 (10) (11) (12) indicate that the volume of true thymic tissue (excluding perivascular space, adipose and fibrous tissue) diminishes progressively throughout life. These observations are consistent with clinical studies showing that, postmyeloablation, circulating naive CD4 ϩ and CD8 ϩ T cells are only found after relatively long periods of time (4-6 mo) and then usually in children and young adults (13) (14) (15) (16) . Viewed in conjunction with a more extensive literature of thymic function in rodents (17) (18) (19) (20) (21) (22) (23) , these data underscore the commonly-held belief (17, 24, 25) that the thymus is not present or not functional in adults.
Even if functioning thymic tissue persisted in adults, it might be quickly eliminated by infection with HIV-1. Viral infection is clearly associated with thymic pathology in HIV-1-infected humans (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) , and SCID-hu mice (37) (38) (39) (40) , simian immunodeficiency virus-infected nonhuman primates (41) (42) (43) , and feline immunodeficiency virus-infected cats (44, 45 
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ϩ medullary thymocytes (37) (38) (39) (40) . HIV-1-infected children with rapid disease progression have been found to have less thymic mass (as measured radiographically) (46) and function (as determined by the level of circulating CD4 ϩ and CD8 ϩ cells) (47) . Finally, the chronic stress associated with HIV-1 disease and its attendant opportunistic infections could predictably lead, in and of itself, to thymic involution.
Given the current availability of highly active antiretroviral therapy, we considered it of interest to revisit the question of thymic function in the setting of adults with HIV-1 disease. In those with a functioning thymus, it might be possible to regenerate a T cell compartment with a diverse T cell receptor repertoire; in those without such thymic function, restoration of the T cell repertoire might require alternative approaches. We used computed tomography to visualize the amount of thymic parenchymal tissue in 99 HIV-1-seropositive and 32 HIV-1-seronegative adults. To ascertain whether thymic tissue visualized by CT scanning was functional, we graded and correlated the presence and amount of thymic tissue with the level of circulating naive (CD45RA ϩ CD62L ϩ ) and memory/effector CD4 ϩ and CD8 ϩ T cells as measured by multiparameter flow cytometry.
Methods
Subjects. A convenience sample of subjects with documented HIV-1 infection was recruited from clinics and community organizations in the San Francisco Bay Area between August 1995 and June 1997. Efforts were made to balance entry of subjects across three age strata (20-29, 30-39, 40-49 yr) and two strata of CD4 counts ( Ͻ 500, Ն 500 cells/ l). HIV-1-uninfected controls were frequency matched by age strata. Prospective subjects were excluded if they had an acute illness and/or a prior medical condition known to have effects on the thymus (e.g., myasthenia gravis, hyperthyroidism, lymphoma, or cachexia).
The protocol was approved by the UCSF Committee on Human Research.
Chest tomography. After written informed consent was obtained, noncontrast chest CTs were performed on a CT scanner (9800; General Electric Co., Milwaukee, WI), with contiguous 5-mm sections obtained at end expiration from the sternal notch to the xiphoid. A thymic index was scored (by B.H. Gross and I.R. Francis) on a grading scale of 0-5: 0 -no soft tissue, with the thymus entirely replaced by fat; 1 -minimal soft tissue, barely recognizable; 2 -minimal soft tissue, more obvious; 3 -moderate soft tissue; 4 -moderate soft tissue of greater extent, almost mass like; and 5 -mass-like appearance, of concern for hyperplasia or thymoma. Representative images from HIV-1-seropositive adults are shown in Fig. 1 . Most ( Ͼ 95%) of the scores fell in the range of 1-4. Before data analysis, thymic scores of 3 or greater were designated to represent abundant thymic tissue. The radiologists were blinded to CD4 count and to HIV-1 serostatus. When all films were reviewed in a blinded manner for a second time and 31 randomly selected films were reviewed for a third time, 98% of the scores were within one grade of each other; the changes did not affect any of the conclusions below.
Flow cytometry. Naive or memory/effector CD4 ϩ and CD8 ϩ T cells were discriminated as described by Roederer et al. (48) . Briefly, peripheral blood mononuclear cells were selected by scatter gates, divided into CD4 ϩ or CD8 ϩ T cell subpopulations, and then subdivided into naive (CD45RA Of those HIV-1-seropositive subjects in the 40 ϩ group, 39 were in the range of 40-49 yr old and five were in the range of 50-59 yr old. The years after seroconversion were self reported by 87 subjects and likely represent an underestimate. The CD4 ϩ T cell counts were obtained within 0 to 5 (mean ϭ 1) months of the CT scan. 
Results
Thymic tissue in HIV-1-seropositive adults. Our cross-sectional study stratified subjects into groups between the ages of 20-59; those that were HIV-1 seropositive were further subdivided into groups with CD4 counts that were either greater than or less than 500 cells/ l ( Table I ). The median age of the 99 HIV-1-seropositive subjects and the 32 HIV-1-seronegative subjects was 39 and 32 yr, respectively.
Younger subjects demonstrated larger amounts of thymic tissue by noncontrast chest CT ( Fig. 1) than those who were older, whether they were HIV-1 seropositive (Fig. 2 A ) or HIV-1 seronegative (Fig. 2 B ) ( n ϭ 99, Spearman r ϭ Ϫ 0.39, P ϭ 0.0001 for HIV-1 seropositives; n ϭ 32, r ϭ Ϫ 0.73, P ϭ 0.0001 for HIV-1 seronegatives). There was also a statistically significant association between decreasing amounts of thymic tissue and longer durations of infection with HIV-1 (Fig. 2 C ) ( n ϭ 87, r ϭ Ϫ 0.31, P ϭ 0.003). Subjects with a longer duration of infection were older (n ϭ 87, r ϭ 0.45, P ϭ 0.0001) and tended to have lower CD4 counts (n ϭ 87, r ϭ Ϫ0.09, P ϭ 0.38). On multivariate logistic regression analysis (Table II) , the relationship between thymic index and duration of infection was observed to be confounded by age: subjects who had been infected longer were likely to have a lower thymus index simply because they were also older. However, in the HIV-1-seropositive subjects, bivariate analysis showed that higher thymic index was associated with higher CD4 count (Fig. 2 D) (n ϭ 99, r ϭ 0.21, P ϭ 0.04), an association which persisted after controlling for age and duration of infection in multivariate logistic analysis (Table II) and stratified analysis (see Fig. 5) .
Correlation of circulating naive T cells with thymic tissue.
ϩ T cells (i.e., thymic emigrants that have not yet undergone antigen-driven expansion) are phenotypically distinguishable from memory/effector T cells by their coexpression Figure 2 . Thymic index relative to age, serostatus, years since seroconversion, and CD4 count. The thymic index for 99 HIV-1-seropositive (A) and 32 HIV-1-seronegative (B) subjects is shown relative to age. For the HIV-1-seropositive subjects, the thymic index is also correlated with years since seroconversion (C) and the absolute number of CD4 ϩ T cell/l (D). Solid bars represent means for each group; dotted lines represent the standard error of the mean. All associations are statistically significant and the association between thymic index and the CD4 count is independent of age (see text and Table II 
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Ϫ were grouped together as memory/effector T cells (Fig. 3) .
The HIV-1-uninfected controls, when compared with the HIV-1-infected subjects, were found to have higher CD4 ϩ absolute numbers (P ϭ 0.0001), lower CD8 ϩ absolute numbers (P ϭ 0.0001), and higher absolute numbers and percentages of naive CD4 ϩ and CD8 ϩ cells (P Ͻ 0.004). The thymic index in the uninfected group was significantly associated with the absolute number (Fig. 4, A and B) and percentage (Fig. 4, C and 
D) of naive CD4
ϩ and CD8 ϩ T cells (r ϭ 0.36-0.38, P Ͻ 0.05 for each association). Amongst the HIV-1-seropositive adults, there was a significant correlation between the absolute CD4 ϩ T cell count and the percentage of circulating naive CD4 ϩ T cells (n ϭ 37, r ϭ 0.41, P ϭ 0.004), confirming previously published observations (48) . There was also a significant correlation between the thymic index and both the absolute number (n ϭ 37, r ϭ 0.37, P ϭ 0.02) (Fig. 4 A) and the percentage (n ϭ 47, r ϭ 0.35, P ϭ 0.02) (Fig. 4 C) of circulating naive CD4 ϩ T cells. These associations persisted after controlling for age (Cochran-Mantel-Haenszel 2 analysis; P Ͻ 0.04). There was no significant association between thymic index and the absolute number (Fig. 4 B) or percentage (Fig. 4 D) of CD8 ϩ naive T cells.
Enhanced abundance of thymus in some HIV-1-seropositive adults. Closer inspection of the data revealed two circumstances in which HIV-1 disease is associated with more and not less thymic tissue. First, abundant thymic tissue is particularly prevalent in younger seropositive subjects (Յ 39 yr) with a CD4 count in the range of 300-500 CD4 ϩ T cells/l. Over 93% of younger subjects in this CD4 range had abundant thymic tissue, a prevalence which was higher than that found in either the Ͼ 500 or the 100-300 CD4 ϩ T cell strata (Fischer's exact test; P ϭ 0.06 and 0.03, respectively) (Fig. 5 B) . Secondly, thymic tissue persisted in older subjects (Ͼ 39 yr) who were HIV-1 seropositive but not in those who were HIV-1 seronegative. Thus, abundant thymic tissue was not found in older seronegative subjects (0/10) but was found in 50% (5/10) of seropositive subjects of comparable age and CD4 count, representing a significantly higher prevalence in the HIV-1-infected group (Fischer's exact test; P ϭ 0.03) ( Table I , Fig. 5 C) . Of note, abundant thymic tissue in these older (Ͼ 39 yr) HIV-1-infected subjects was associated with signs of thymic function, e.g., a higher absolute number and percentage of naive CD4 ϩ T cells (n ϭ 25, r ϭ 0.36, P ϭ 0.07; n ϭ 23, r ϭ 0.41, P ϭ 0.05, respectively).
Discussion
The above data indicate that CT appearance of the thymus is highly correlated with circulating naive T cell subpopulations in both HIV-1-seropositive and HIV-1-seronegative adults. Abundant thymic tissue (with a score of 3 or greater) is present in many (47/99) HIV-1-seropositive adults. Among HIV-1-seropositive subjects under age 40, thymic tissue may be responsive to declining CD4 ϩ T cell counts, which could explain the persistence of thymic tissue observed in older HIV-1-infected subjects. Alternatively, the high prevalence of thymic tissue in people over 39 yr of age may be due to increased survival among adults with thymus. In either case, and by inference, the thymus may be functional in some but not all individuals with HIV-1 disease.
This inference must be considered with two caveats in mind. First, the images visualized by CT may not represent true thymic tissue but a pathologic accumulation instead, e.g., of inflammatory or malignant cells. Direct biopsy studies of thymic tissue from HIV-1-seropositive adults will be necessary to resolve this issue. Secondly, it has not been proven that all CD45RA ϩ
CD62L
ϩ human T cells emanate directly from the thymus; some, for instance, may be memory cells that have reverted in phenotype (23) . Although the CD45RA ϩ CD62L ϩ phenotypic definition of a naive T cell is more accurate than the use of the CD45RA ϩ phenotype alone (48, 49, 51) , future studies will be necessary to confirm that this population has additional attributes of recent thymic emigrants, e.g., a diverse T cell receptor repertoire and the presence of T cell receptor rearrangement deletion circles (52, 53) . Notwithstanding these caveats, it is striking that there is such a high correlation between the presence of abundant thymus and the circulating levels of provisionally assigned naive CD4 ϩ T cells, suggesting that the thymus is contributing to this pool of cells in adults.
The possibility that functioning thymic tissue may be present in some HIV-1-seropositive adults is not completely unanticipated by the prior literature. Thymic involution certainly occurs in most adults, but the course is variable and even subjects as old as 107 yr have been found to have histologically normal thymic tissue (as defined by demarcated cortical and medullary regions and by the presence of immature cells posi- Increasing age 1.70 P ϭ 0.0003 1.64 P ϭ 0.006 Increasing years of infection 1.62 P ϭ 0.0003 1.25 P ϭ 0.23 Decreasing CD4 count 1.33 P ϭ 0.02 1.37 P ϭ 0.02
Seropositive subjects (n ϭ 87) with valid data for all predictors were analyzed. Thymic index was grouped before any analysis into two categories ( Ͻ 3, Ն 3), representing nonabundant and abundant thymic tissue. The range of each predictor variable was grouped into six equal intervals to standardize the variance before analysis. Ages were grouped into 5-yr intervals increasing from ages 20 to 24, years of infection were grouped into 3-yr intervals increasing from years 0 to 2, and CD4 counts were grouped into intervals of 100 cells/l decreasing from cells counts Ͼ 500 cells/l. Odds ratios represent the odds of having thymic index Ͻ 3 for any interval of the predictor variable relative to the previous interval. Analysis of each interval as an independent variable indicated consistent dose-response relationships. Allowance for the unexpected increased prevalence of thymic tissue among young subjects with mildly decreased CD4 ϩ counts (see Fig. 5 ) significantly improved the fit of the logistic model (P ϭ 0.03) but did not substantially change the overall assciation between CD4 count and thymic mass. Consideration of other statistical interactions did not significantly improve model fit and did not substantially change model estimates.
tive for terminal deoxytransferase) (2, (54) (55) (56) (57) (58) . In adult mice, thymocyte turnover is slower than it is in young mice, but nonetheless measurable: 10 5 cells/d in the adult (6-mo-old) mouse as opposed to Ͼ 10 6 cells/d in the young mouse (20) (21) (22) (23) . Finally, phenotypic analyses of naive T cells in HIV-1-seropositive adults as well as estimates of their turnover are consistent with, but not heretofore linked directly with, the presence of thymic function at older ages (48, (59) (60) (61) .
The high frequency of thymic tissue found in HIV-1-seropositive adults raises the possibility that thymic function may actually be enhanced in some who are HIV-1 infected. This possibility is underscored by the observation that most infected individuals with a CD4 count in the range of 300-500 cells/l have a high thymic index (scores of 3-4). In the same manner that thymic rebound has been observed in adults after myeloablation (62) (63) (64) (65) (66) (67) and after correction of Cushing's disease (68, 69) , the peripheral T cell depletion induced by HIV-1 may drive renewed thymocyte maturation in an otherwise dormant thymic remnant. Thymic rebound may contribute to host compensation during the early phase of HIV-1 infection, characterized by maintenance of total T cell counts (70) . If so, peripheral total T cell depletion may occur when thymopoiesis is finally disrupted (e.g., after direct infection and destruction of the organ by HIV-1). Reciprocally, immune reconstitution in late stage disease may be possible if disruption of thymopoiesis is reversible. These implications bear potential importance to the understanding of HIV-1 disease and to the design of clinical trials of highly active antiretroviral therapy and vaccines in HIV-1-infected patients. It will accordingly be critical to establish definitive evidence of thymic function in future studies of HIV-1-infected adults. ϩ (A and C, respectively) and CD8 ϩ (B and D, respectively) T cells. For HIV-1-infected subjects, data from 37 and 47 subjects were available for analysis of absolute numbers and percent cells, respectively. For HIV-1-uninfected subjects, data from 32 subjects were available for analysis of absolute number and percent cells. These values were calculated as described in the Fig. 3 legend. Means and SEMs are shown. 
